Patrik Hildingson, Vice President of Communications and Public Affairs at Swedish Match, stated on November 21st that only five percent of the population in Sweden, both men and women, smoke cigarettes, according to B92.
At the "Rethink: Learning from Sweden" conference, he emphasized that Sweden introduced innovations in the 1970s with loose tobacco placed in pouches—snus.
"We've arrived at snus, a product used under the upper lip, which has become the first and best alternative to cigarettes in America," said Hildingson. He noted that since its introduction, snus has shown a continuous growth trend.
"According to public health statistics, we can see that since the 1980s, due to the rise of snus, there has been a decline in various lung diseases, and Swedish men have the lowest cancer rates in the world," Hildingson said.
Tomaso Di Giovanni, Vice President of International Communications at Philip Morris International(PMI), said that innovations have always been used to address the world's most pressing problems and that the same principle can be applied to tobacco and vapes.
"We created three very simple alternatives that should guide decisions for companies, public health, academia, and NGOs. These are: if you don't smoke, don't start; if you smoke, quit; If you don't quit, change," Di Giovanni said.
He also noted that in 2008, PMI invested $12 billion in developing alternative products, with R&D centers in Switzerland and Singapore, and ranking fifth in European patent filings.
He announced further investments in Serbia to focus more on cigarette alternatives.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
